期刊文献+

儿童Clq肾病的临床分析 被引量:2

Clinical analysis of Clq nephropathy in children
下载PDF
导出
摘要 目的探讨Clq肾病的临床表现、病理改变、治疗效果和随访结果的特点,以加强对Clq肾病的认识。方法选择上海交通大学医学院附属新华医院儿内科2002年1月—2007年6月明确诊断为Clq肾病的患儿17例,从发病情况、临床表现、病理改变、治疗效果和随访结果5个方面进行分析。结果同期共389例患儿因各种肾脏疾病行经皮肾脏穿刺活组织检查术,参照Clq肾病的诊断标准,明确诊断为Clq肾病者共17例,占同期肾脏活组织检查的4.4%。其中男7例,女10例,行肾脏活组织检查时的年龄为2~11岁。临床表现为肾病综合征6例,大量蛋白尿3例,血尿8例(其中1例表现为持续肉眼血尿).肾功能均正常。肾脏病理检查显示,5例(5/17)为微小病变(MCD),10例(10/17)为局灶节段性肾小球硬化(FSGS),2例(2/17)为轻微病变(表现为系膜节段性轻度增生)。免疫荧光检查示,肾小球系膜区均以Clq沉积为主,强度为(++)~(+++),同时伴C3、IgM沉积者较多,未见"满堂亮"表现。电子显微镜下,除1例未见肾小球外,其余16例均可见电子致密物分布在系膜区和(或)内皮下。1例患儿在肾脏活组织检查后失访,其余16例予以治疗和随访.平均随访时间为(28±18)个月。1例轻微病变患儿仅应用血管紧张素转换酶抑制剂(贝那普利)治疗,目前完全缓解。其余15例予泼尼松治疗,其中3例加用其他免疫抑制剂,完全缓解7例(7/15),分别是2例FSGS、1例轻微病变和4例MCD患儿;部分缓解7例(7/15),分别是6例FSGS和1例MCD患儿;无效1例(1/15),病理表现为FSGS,但目前肾功能正常。结论Clq肾病临床表现多样化,病理改变以FSGS和MCD为主,治疗效果和长期预后与病理改变密切相关,FSGS的疗效和长期预后不容乐观。 Objective To summarize the clinical manifestations, pathological changes, response to treatment and the follow-up outcomes of children with Clq nephropathy, so as to better our understanding of the disease. Methods The incidence, clinical manifestations, pathologic findings, and outcomes of treatment and follow-up were analyzed in 17 children with Clq nephropathy, who were treated in Xinhua Hospital from Jan. 2002 to Jun. 2007. Results Seven- teen (4.4%) Clq nephropathy patients, including 7 boys and 10 girls, aged from 2 to 11 years old, were identified from 389 children who underwent renal biopsy due to various reasons. Six patients presented with nephrotic syndrome, 3 cases with nephritic proteinuria and 8 cases with hematuria, including one with persistent gross hematuria. Light microscopy showed focal segmental glomerulo sclerosis (FSGS) in 10 (10/17), minimal change disease (MCD) in 5 (5/17) and focal mesangial proliferative glomerulonephritis in 2 (2/17). Immunofluorescence revealed Clq depositing dominantly in all 17 patients ( + +, + + +), whereas IgM and C3 were more consistent. No “full-house” pattern was detected. Electron-dense deposits were evident in 16 patients. Sixteen patients were followed-up and the mean follow-up period was (28±18) months. One patient treated with only angiotensin-converting enzyme inhibitors had good outcome. Fifteen patients were treated with corticosteroids and 3 of them received additional immunosuppressive agents. Seven patients achieved complete remission, in which 4 presented with MCD, 2 with FSGS and 1 with focal mesangial proliferative glomerulonephritis. Six patients with FSGS and 1 patient with MCD experienced partial remission. The re- maining 1 patient with FSGS showed poor response to corticosteroids and other immunosuppressive therapy (cyclophosphamide and mycofenolate mofetil). All the patients had normal renal function at last follow-up. Conclusion Childhood Clq nephropathy has various clinical presentations.
出处 《上海医学》 CAS CSCD 北大核心 2008年第6期400-404,共5页 Shanghai Medical Journal
关键词 Clq肾病 病理改变 临床表现 治疗 预后 儿童 Clq nephropathy Histopathologic findings Clinical manifestation Treatment Prognosis Children
  • 相关文献

参考文献10

  • 1Jennette J C, Hipp C G. Immunohistopathologie evaluation of Clq in 800 renal biopsy specimens. Am J Clin Pathol, 1985, 83: 415-420. 被引量:1
  • 2Jennette J C, Falk R J. Clq nephropathy//Massry S G, Glassock R J. Textbook of nephrology, 4th ed. Philadelphia: Lippineott Williams & Wilkins, 2004: 730-733. 被引量:1
  • 3Lau K K, Gaber L W, Delos Santos N M, et al. Clq nephropathy: features at presentation and outcome. Vediatr Nephrol, 2005, 20:744-749. 被引量:1
  • 4Fukuma Y, Hisano S, Segawa Y, et al. Clinicopathologic correlation of Clq nephropathy in children. Am J Kidney Dis, 2006, 47: 412-418. 被引量:1
  • 5Kersnik Levart T, Kenda R B, Avgustin Cavi? M, et al. ClQ nephropathy in children. Pediatr Nephrol, 2005, 20:1756-1761. 被引量:1
  • 6Nishida M, Kawakatsu H, Okumura Y, et al. Clq nephropathy with asymptomatic urine abnormalities. Pediatr Nephrol, 2005, 20: 1669-1670. 被引量:1
  • 7Hashimoto S, Ogawa Y, Ishida T, et al. Steroid-sensitive nephrotic syndrome associated with positive Clq immunofluorescence. Clin Exp Nephrol, 2004, 8: 266-269. 被引量:1
  • 8Markowitz G S, Schwimmer J A, Stokes M B, et al. Clq nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int, 2003, 64:1232-1240. 被引量:1
  • 9Sharman A, Furness P, Feehally J. Distinguishing Clq nephropathy from lupus nephritis. Nephrol Dial Transplant, 2004, 19:1420 -1426. 被引量:1
  • 10刘建华,何威逊,罗运九,朱光华,方明俊.八例C1q肾病的诊断与鉴别诊断[J].中华儿科杂志,2002,40(12):716-719. 被引量:5

二级参考文献1

共引文献4

同被引文献34

  • 1Braden G L, Mulhern J G, O'Shea M H, et al. Changing incidence of glomerular diseases in adults. Am J Kidney Dis, 2000, 35: 878-883. 被引量:1
  • 2Li L S, Liu Z H. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int, 2004, 66: 920-923. 被引量:1
  • 3Zhou FD, Zhao M H, Zou W Z, et al. The changing spectrum of primary glomerular diseases within 15 years: a survey of 3331 patients in a single Chinese centre. Nephrol Dial Transplant, 2009, 24: 870-876. 被引量:1
  • 4Barisoni L, Schnaper H W, Kopp J B. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol, 2007, 2: 529-542. 被引量:1
  • 5Bongers E M, Huysmans F T, Levtchenko E, et al. Genotypephenotype studies in nail-patella syndrome show that LMXIB mutation location is involved in the risk of developing nephropathy. Eur J Hum Genet, 2005, 13: 935-946. 被引量:1
  • 6Guery B, Choukroun G, No? I L H, et al. The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA (Leu) gene mutation. J Am Soc Nephrol, 2003, 14: 2099-2108. 被引量:1
  • 7Quinzii C, Naini A, Salviati L, et al. A mutation in parahydroxybenzoate-polyprenyl transferase ( COQ2 ) primary coenzyme Q10 deficiency. Am J Hum Genet, 2006, 78:345-349. 被引量:1
  • 8Franceschini N, North K E, Kopp J B, et al. NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Genet Med, 2006, 8: 63-75. 被引量:1
  • 9Hinkes B, Wiggins R C, Gbadegesin R, et al, Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet, 2006, 38: 1397-1405. 被引量:1
  • 10Zenker M, Aigner T, Wendler O, et al. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet, 2004, 13: 2625-2632. 被引量:1

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部